For a wide range of applications, paper materials require effective protection against the destructive effect of water, which is most effectively realized by superhydrophobic coatings. In recent years, a considerable amount of scientific research has been carried out in this area, focusing particularly on biogenic resources. With this contribution, we go one step further and examine how biogenic materials can be transferred into aqueous dispersions and coated onto paper via existing technologies. With this paper coating, based on a hydrophobic cellulose derivative in combination with a structurally similar wax, thermally regenerable flower-like surface morphologies are obtained via self-assembly, where the hydrophobic cellulose polymer acts as a structural template for the co-crystallization of the wax component. Such hydrophobic structures in the low micrometer range ensure perfectly water-repellent paper surfaces with contact angles > 150° starting from coating weights of 5 g/m². The dispersion can be successfully applied to a variety of commercially available paper substrates, whereby the effects of different roughness, porosity, and hydrophobicity were investigated. In this context, a certain roughness of the base paper (S_a ~ 1.5–3 µm) was found to be beneficial for achieving the highest possible contact angles. Furthermore, the approach proved to be paper process-compatible, recyclable, and regenerable, whereby the processing temperatures allow the coating properties to be thermally generated in situ. With this work, we demonstrate how biogenic waxes are very well suited for superhydrophobic, regenerative coatings and, importantly, how they can be applied from aqueous coatings, enabling simple transfer into the paper industry.

Among non-viral vectors, cationic polymers, such as poly(propylene imine) (PPI), play a prominent role in nucleic acid delivery. However, limitations of polycationic polymer-based DNA delivery systems are (i) insufficient target specificity, (ii) unsatisfactory transgene expression, and (iii) undesired transfer of therapeutic DNA into non-target cells. We developed single-chain antibody fragment (scFv)-directed hybrid polyplexes for targeted gene therapy of prostate stem cell antigen (PSCA)-positive tumors. Besides mono-biotinylated PSCA-specific single-chain antibodies (scFv(AM1-P-BAP)) conjugated to neutravidin, the hybrid polyplexes comprise β-cyclodextrin-modified PPI as well as biotin/maltose-modified PPI as carriers for minicircle DNAs encoding for Sleeping Beauty transposase and a transposon encoding the gene of interest. The PSCA-specific hybrid polyplexes efficiently delivered a GFP gene in PSCA-positive tumor cells, whereas control hybrid polyplexes showed low gene transfer efficiency. In an experimental gene therapy approach, targeted transposition of a codon-optimized p53 into p53-deficient HCT116^{p53−/−/PSCA} cells demonstrated decreased clonogenic survival when compared to mock controls. Noteworthily, p53 transposition in PTEN-deficient H4^PSCA glioma cells caused nearly complete loss of clonogenic survival. These results demonstrate the feasibility of combining tumor-targeting hybrid polyplexes and Sleeping Beauty gene transposition, which, due to the modular design, can be extended to other target genes and tumor entities.